Clinical trial
A Gliadin Peptide Regulated the INF-α Immune Response in Celiac Small Intestine and in an En-terocyte Cell Line
NCT03221647 is registered in ClinicalTrials.gov with Federico II University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Gliadin Peptide Regulated the INF-α Immune Response in Celiac Small Intestine and in an En-terocyte Cell Line
- Lead sponsor
- Federico II University
- Phase
- Observational
- Overall status
- Completed
- Start date
- January 10, 2013
- Completion date
- July 1, 2017
- Enrollment
- 53 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.